[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Rani Therapeutics Holdings Inc Cl A (RANI)

Rani Therapeutics Holdings Inc Cl A (RANI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Rani Therapeutics Holdings Inc Cl A 2051 RINGWOOD AVENUE SAN JOSE CA 95131 USA

www.ranitherapeutics.com Employees: 71 P: 408-457-3700

Sector:

Medical

Description:

Rani Therapeutics Holdings Inc. is a clinical stage biotherapeutics company. It focused on advancing technologies to enable the development of orally administered biologics. Rani Therapeutics Holdings Inc. is based in SAN JOSE, Calif.

Key Statistics

Overview:

Market Capitalization, $K 134,824
Enterprise Value, $K 116,204
Shares Outstanding, K 123,692
Float, K 90,629
% Float 73.27%
Short Interest, K 8,946
Short Float 7.23%
Days to Cover 13.57
Short Volume Ratio 0.38
% of Insider Shareholders 26.73%
% of Institutional Shareholders 30.19%

Financials:

Annual Sales, $ 1,630 K
Annual Net Income, $ -29,670 K
Last Quarter Sales, $ 1,710 K
Last Quarter Net Income, $ -7,030 K
EBIT, $ -34,650 K
EBITDA, $ -33,820 K

Growth:

1-Year Return 51.09%
3-Year Return -73.99%
5-Year Return 0.00%
5-Year Revenue Growth 254.35%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.04 on 05/15/26
Next Earnings Date 08/06/26
Earnings Per Share ttm -0.41
EPS Growth vs. Prev Qtr 42.86%
EPS Growth vs. Prev Year 81.82%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

RANI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -206.45%
Return-on-Assets % -83.95%
Profit Margin % -1,820.25%
Debt/Equity 0.00
Price/Sales 66.99
Price/Cash Flow N/A
Price/Book 3.08
Book Value/Share 0.29
Interest Coverage -13.17
60-Month Beta 0.74
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.